Artificial Cornea and Corneal Implant Market market is expected to grow at a CAGR of 10.1% during the forecasted period | Evolve Business Intelligence

As per the study initiated by Evolve Business Intelligence, the global Artificial Cornea and Corneal Implant Market size accounted for USD 100.1 Million in 2023, growing at a CAGR of 10.1% from 2023 to 2033. An artificial cornea, also known as a corneal implant, is a prosthetic device designed to replace or assist the natural cornea of the eye. The cornea is the transparent front part of the eye that covers the iris, pupil, and anterior chamber. It plays a crucial role in focusing light onto the retina, enabling clear vision.

Request/Download PDF Sample: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021561

As the incidence of corneal diseases and conditions rises, there is a growing demand for effective treatments, including artificial corneas. Ongoing advancements in materials, design, and surgical techniques contribute to the development of more effective and reliable artificial corneas. The aging population is more prone to eye-related conditions, and the demand for corneal implants may increase as a result. Increased awareness among patients and healthcare professionals about the availability and benefits of artificial corneas can drive market growth. Improved accessibility to these technologies also plays a role.

Key Players
Some of the major Artificial Cornea and Corneal Implant Market players holding high market shares include Cornea Biosciences, LinkoCare Life Sciences AB, CorNeat Vision, AJL Ophthalmic, and Mediphacos. These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders. Some of the other major market players include Presbia plc, DIOPTEX GmbH, EyeYon Medical, Aurolab, CorneaGen Inc

For More Information: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021561

Segmental Analysis
Based on type, the Artificial Cornea and Corneal Implant market is segmented into Human Cornea and Artificial Cornea. The use of human corneas for transplantation is the most common type of corneal transplant. Human corneas are donated from deceased individuals and are considered to be the gold standard for corneal transplantation. However, there is a shortage of donor corneas, which can limit the availability of this type of transplant.
Based on transplant type, the Artificial Cornea and Corneal Implant market is Penetrating Keratoplasty, Endothelial Keratoplasty, Anterior Lamellar Keratoplasty, and Keratoprosthesis. PKP is the most common type of corneal transplant. In PKP, the entire thickness of the damaged cornea is removed and replaced with a donor cornea. PKP is a complex surgery that requires a skilled surgeon.
Based on disease indication, the Artificial Cornea and Corneal Implant market is a Fuchs' Dystrophy, Fungal Keratitis, Keratoconus, and Others. Fuchs' dystrophy is the leading disease indication for corneal transplants. Fuchs' dystrophy is a degenerative disease of the cornea that causes the endothelial cells, which are responsible for maintaining the cornea's clarity, to die. This can lead to vision loss.

Based on End Use, the Artificial Cornea and Corneal Implant market is Hospitals, Ambulatory Surgical Centers, and Specialty Clinics. Hospitals are the largest end-users of artificial corneas and corneal implants. Hospitals are equipped with the facilities and staff to perform complex corneal transplant surgeries.

Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, BeNeLux, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Rest of Asia Pacific)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)
• Latin America (Mexico, Brazil, Argentina, Rest of Latin America)

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from Fortune's global 2000 companies.

This release was published on openPR.